Evaluation of Reference Regions for (R)-[11C]PK11195 Studies in Alzheimer's Disease and Mild Cognitive Impairment
暂无分享,去创建一个
Ronald Boellaard | Alie Schuitemaker | Philip Scheltens | Adriaan A Lammertsma | Cees Jonker | Marc A Kropholler | Bart N M van Berckel | Reina W Kloet | R. Boellaard | P. Scheltens | M. Lubberink | A. Lammertsma | M. Kropholler | A. Schuitemaker | B. V. van Berckel | C. Jonker | R. Kloet | Mark J Lubberink
[1] R B Banati,et al. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. , 2000, Brain : a journal of neurology.
[2] Yuji Nagai,et al. Novel peripheral benzodiazepine receptor ligand [11C]DAA1106 for PET: An imaging tool for glial cells in the brain , 2004, Synapse.
[3] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[4] H. Kung,et al. Noninvasive quantification of dopamine D2 receptors with iodine-123-IBF SPECT. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[5] Gert Luurtsema,et al. Optimizing an online SPE-HPLC method for analysis of (R)-[11C]1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide [(R)-[11C]PK11195] and its metabolites in humans. , 2005, Nuclear medicine and biology.
[6] Eric Achten,et al. Assessment of Neuroinflammation and Microglial Activation in Alzheimer’s Disease with Radiolabelled PK11195 and Single Photon Emission Computed Tomography , 2003, European Neurology.
[7] Ronald Boellaard,et al. Evaluation of Methods for Generating Parametric (R)-[11C]PK11195 Binding Images , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[8] Elizabeth L Sampson,et al. In vivo detection of microglial activation in frontotemporal dementia , 2004, Annals of neurology.
[9] R B Banati,et al. [11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy , 2003, Neurology.
[10] W. J. Lorenz,et al. Performance evaluation of the whole-body PET scanner ECAT EXACT HR + , 1997 .
[11] N L Foster,et al. PET of peripheral benzodiazepine binding sites in the microgliosis of Alzheimer's disease. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[12] B. Gulyás,et al. Drug distribution in man: a positron emission tomography study after oral administration of the labelled neuroprotective drug vinpocetine , 2002, European Journal of Nuclear Medicine and Molecular Imaging.
[13] Stephen M. Smith,et al. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm , 2001, IEEE Transactions on Medical Imaging.
[14] G. Kreutzberg. Microglia: a sensor for pathological events in the CNS , 1996, Trends in Neurosciences.
[15] R. Myers,et al. Long-term trans-synaptic glial responses in the human thalamus after peripheral nerve injury , 2001, Neuroreport.
[16] G Brix,et al. Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[17] Guy Marchal,et al. Multimodality image registration by maximization of mutual information , 1997, IEEE Transactions on Medical Imaging.
[18] Stephen M Smith,et al. Fast robust automated brain extraction , 2002, Human brain mapping.
[19] R B Banati,et al. Mills’ and other isolated upper motor neurone syndromes: in vivo study with 11C-(R)-PK11195 PET , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[20] Ronald Boellaard,et al. Characteristics of a new fully programmable blood sampling device for monitoring blood radioactivity during PET , 2001, European Journal of Nuclear Medicine.
[21] Ryuji Nakao,et al. Quantitative Analysis for Estimating Binding Potential of the Peripheral Benzodiazepine Receptor with [11C]DAA1106 , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[22] R. Boellaard,et al. Evaluation of Reference Tissue Models for the Analysis of [11C](R)-PK11195 Studies , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[23] F. Turkheimer,et al. Reference and target region modeling of [11C]-(R)-PK11195 brain studies. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[24] G. Glatting,et al. Imaging of activated microglia with PET and [11C]PK 11195 in corticobasal degeneration , 2004, Movement disorders : official journal of the Movement Disorder Society.
[25] Gerald Q. Maguire,et al. Comparison and evaluation of retrospective intermodality brain image registration techniques. , 1997, Journal of computer assisted tomography.
[26] Roger N Gunn,et al. In-vivo measurement of activated microglia in dementia , 2001, The Lancet.
[27] E. Tangalos,et al. Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .
[28] R B Banati,et al. In vivo visualization of activated glia by [11C] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion. , 2001, Brain : a journal of neurology.
[29] Ronald Boellaard,et al. Development of a Tracer Kinetic Plasma Input Model for (R)-[11C]PK11195 Brain Studies , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[30] B. Gulyás,et al. [11C]Vinpocetine: a prospective peripheral benzodiazepine receptor ligand for primate PET studies , 2005, Journal of the Neurological Sciences.
[31] C. C. Watson,et al. New, faster, image-based scatter correction for 3D PET , 1999, 1999 IEEE Nuclear Science Symposium. Conference Record. 1999 Nuclear Science Symposium and Medical Imaging Conference (Cat. No.99CH37019).
[32] F. Turkheimer,et al. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study , 2004, Neurobiology of Disease.
[33] J. Korf,et al. In vivo evaluation in mice and metabolism in blood of human volunteers of [123I]iodo-PK11195: a possible single-photon emission tomography tracer for visualization of inflammation , 1999, European Journal of Nuclear Medicine.
[34] A. Lammertsma,et al. Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.
[35] Cerebral uptake of [ethyl-11C]vinpocetine and 1-[11C]ethanol in cynomolgous monkeys: a comparative preclinical PET study. , 2002, Nuclear medicine and biology.
[36] S. Hume,et al. Synthesis of the enantiomers of [N-methyl-11C]PK 11195 and comparison of their behaviours as radioligands for PK binding sites in rats. , 1994, Nuclear medicine and biology.
[37] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[38] B. Kiss,et al. PET studies on the brain uptake and regional distribution of [11C]vinpocetine in human subjects , 2002, Acta neurologica Scandinavica.
[39] Christopher J. Taylor,et al. A cluster analysis approach for the characterization of dynamic PET data , 1996 .
[40] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.